{"pmid":32404490,"title":"Is COVID-19 more severe in older men?","text":["Is COVID-19 more severe in older men?","Postgrad Med J","Liang, Xiaopeng","32404490"],"journal":"Postgrad Med J","authors":["Liang, Xiaopeng"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404490","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/postgradmedj-2020-137867","topics":["Mechanism","Treatment"],"weight":1,"_version_":1666802845460987904,"score":9.490897,"similar":[{"pmid":32389499,"title":"Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.","text":["Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized by a high mortality of elderly men with age-related comorbidities. In most of these patients, uncontrolled local and systemic hyperinflammation induces severe and often lethal outcomes. The aging process is characterized by the gradual development of a chronic subclinical systemic inflammation (inflamm-aging) and by acquired immune system impairment (immune senescence). Here, we advance the hypothesis that four well-recognized features of aging contribute to the disproportionate SARS-CoV-2 mortality suffered by elderly men: i. the presence of subclinical systemic inflammation without overt disease, ii. a blunted acquired immune system and type I interferon response due to the chronic inflammation; iii. the downregulation of ACE2 (i.e. the SARS-CoV-2 receptor); and iv. accelerated biological aging. The high mortality rate of SARS-CoV-2 infection suggests that clarification of the mechanisms of inflamm-aging and immune senescence can help combat not only age-related disorders but also SARS-CoV-2 infection.","Cytokine Growth Factor Rev","Bonafe, Massimiliano","Prattichizzo, Francesco","Giuliani, Angelica","Storci, Gianluca","Sabbatinelli, Jacopo","Olivieri, Fabiola","32389499"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized by a high mortality of elderly men with age-related comorbidities. In most of these patients, uncontrolled local and systemic hyperinflammation induces severe and often lethal outcomes. The aging process is characterized by the gradual development of a chronic subclinical systemic inflammation (inflamm-aging) and by acquired immune system impairment (immune senescence). Here, we advance the hypothesis that four well-recognized features of aging contribute to the disproportionate SARS-CoV-2 mortality suffered by elderly men: i. the presence of subclinical systemic inflammation without overt disease, ii. a blunted acquired immune system and type I interferon response due to the chronic inflammation; iii. the downregulation of ACE2 (i.e. the SARS-CoV-2 receptor); and iv. accelerated biological aging. The high mortality rate of SARS-CoV-2 infection suggests that clarification of the mechanisms of inflamm-aging and immune senescence can help combat not only age-related disorders but also SARS-CoV-2 infection."],"journal":"Cytokine Growth Factor Rev","authors":["Bonafe, Massimiliano","Prattichizzo, Francesco","Giuliani, Angelica","Storci, Gianluca","Sabbatinelli, Jacopo","Olivieri, Fabiola"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389499","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cytogfr.2020.04.005","keywords":["covid-19","cardiovascular diseases","host-directed therapies","inflamm-aging","sars-cov-2","interleukin-6"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666528580165697537,"score":47.40819}]}